NephThera Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

NephThera General Information

Description

Developer of nephrology therapeutics committed to discovery and development of therapeutic medicinal products in the field of nephrology. The company through its innovative drug discovery and development platform pursues a precision medicine approach committing to discovery of nephrology therapeutics .

Contact Information

Formerly Known As
SCUR-Alpha 150 GmbH
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Essener Bogen 7
  • 22419 Hamburg
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • Essener Bogen 7
  • 22419 Hamburg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NephThera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NephThera‘s full profile, request access.

Request a free trial

NephThera Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NephThera‘s full profile, request access.

Request a free trial

NephThera FAQs

  • When was NephThera founded?

    NephThera was founded in 2019.

  • Where is NephThera headquartered?

    NephThera is headquartered in Hamburg, Germany.

  • What industry is NephThera in?

    NephThera’s primary industry is Drug Discovery.

  • Is NephThera a private or public company?

    NephThera is a Private company.

  • What is the current valuation of NephThera?

    The current valuation of NephThera is .

  • What is NephThera’s current revenue?

    The current revenue for NephThera is .

  • Who are NephThera’s investors?

    CSL Vifor has invested in NephThera.

  • When was NephThera acquired?

    NephThera was acquired on 01-Jul-2023.

  • Who acquired NephThera?

    NephThera was acquired by Evotec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process